Table 2. Results of association analysis between rs16896059 and clinicopathological characteristics.
| Clinical data information | All(%) | Genotype | P-value | OR | |
| GG(%) | GA+AA(%) | ||||
| Age | |||||
| ≤50 | 43(31.9) | 31(23.0) | 12(8.89) | 0.608 | 1.00(reference) |
| >50 | 92(68.1) | 61(45.2) | 31(23.0) | 1.206 | |
| Degree of Differentiation | |||||
| Low | 89(84.0) | 58(54.7) | 31(29.2) | 0.617 | 1.00(reference) |
| Middle & High | 17(16.0) | 10(9.43) | 7(6.60) | 0.764 | |
| Clinical stage | |||||
| I & II | 36(28.8) | 18(14.4) | 18(14.4) | 0.038 | 1.00(reference) |
| III & IV | 89(71.2) | 62(49.6) | 27(21.6) | 2.296 | |
| Positive lymph node | |||||
| Negative | 37(66.1) | 20(35.7) | 17(30.4) | 0.515 | 1.00(reference) |
| Positive | 19(33.9) | 12(21.4) | 7(12.5) | 1.457 | |
| CA125 | |||||
| ≤65(U/ml) | 23(17.6) | 15(11.5) | 8(6.11) | 0.962 | 1.00(reference) |
| >65(U/ml) | 108(82.4) | 71(54.2) | 37(28.2) | 1.023 | |
| Size of tumor | |||||
| <10 cm | 80(59.3) | 54(40.0) | 26(19.3) | 0.496 | 1.00(reference) |
| ≥10 cm | 55(40.7) | 34(25.2) | 21(15.6) | 0.780 | |
| Tumor histology | |||||
| Serous | 89(65.4) | 58(42.6) | 31(22.8) | 0.877 | 1.00(reference) |
| Other | 47(34.6) | 30(22.1) | 17(12.5) | 0.943 | |